( International Association for the Study of Lung Cancer ) Small cell lung cancer will be the concentrated focus when 100 global experts in the field meet for a workshop hosted by the International Association for the Study of Lung Cancer on April 22-24, 2015 at Memorial Sloan Kettering Cancer Center in New York City.
CHILDREN'S HOSPITAL OF WISCONSIN OPENS NEW FACILITIES FOR TREATMENT OF CANCER AND BLOOD DISORDERS
MILWAUKEE, April 13, 2015 /PRNewswire/ —
Mesothelioma Victims Center Now Focuses On Construction Workers Diagnosed With Mesothelioma And Makes Certain That …
WASHINGTON, April 13, 2015 /PRNewswire/ — The Mesothelioma Victims Center is urging diagnosed victims who were exposed to asbestos while working in the construction industry as a plumber, electrician, carpenter, or insulator to call them at 866-714-6466 to ensure they have the nation's top compensation lawyers, and mesothelioma cancer treatment specialists. The Mesothelioma Victims Center is …
Researchers from Memorial Sloan Kettering Cancer Center are pioneering a new groundbreaking clinical trial for children and young adults with relapsed or treatment-resistant acute lymphocytic leukemia (ALL) by using one of the most promising methods of cancer treatment today, chimeric antigen receptor (CAR) T cells.
UT Southwestern Medical Center Kidney Cancer Program investigators have published what is believed to be the first reported successful use of stereotactic body radiation therapy for an often deadly complication of kidney cancer.
( American Association for Cancer Research ) The American Association for Cancer Research (AACR) is honoring Owen N. Witte, M.D., founding director of the Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research and distinguished professor of microbiology, immunology, and molecular genetics at the University of California, Los Angeles, with the 55th annual AACR G.H.A
Provision Center for Proton Therapy is helping pioneer a new product that will help further protect prostate cancer patients from the effects of radiation therapy.
Astellas Pharma Inc. and The University of Texas MD Anderson Cancer Center today announced the signing of an option agreement to research and develop a new treatment for patients with acute myeloid leukemia (AML).
Art association to meet MURRIETA – The Gem of the Valley Art Association is set to meet at 1:30 p.m.
MD Anderson, Astellas Pharma sign option agreement for monoclonal antibody drug targeting acute myeloid leukemia
( University of Texas M. D. Anderson Cancer Center ) The University of Texas MD Anderson Cancer Center and Astellas Pharma Inc.